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Covalent modification of 7 W55C nicotinic acetylcho-
line receptors (nAChR) with the cysteine-modifying reagent
[2-(trimethylammonium)ethyl] methanethiosulfonate
(MTSET) produces receptors that are unresponsive to ace-
tylcholine, whereas methyl methanethiolsulfonate (MMTS)
produces enhanced acetylcholine-gated currents. Here, we
investigate structural changes that underlie the opposite
effects of MTSET and MMTS using acetylcholine-binding
protein (AChBP), a homolog of the extracellular domain of
the nAChR. Crystal structures of Y53C AChBP show that MT-
SET-modification stabilizes loop C in an extended conforma-
tion that resembles the antagonist-bound state, which parallels
our observation that MTSET produces unresponsive W55C
nAChRs. The MMTS-modified mutant in complex with acetyl-
choline is characterized by a contracted C-loop, similar to
other agonist-bound complexes. Surprisingly, we find two ace-
tylcholine molecules bound in the ligand-binding site, which
might explain the potentiating effect of MMTS modification in
W55C nAChRs. Unexpectedly, we observed in the MMTS-
Y53C structure that ten phosphate ions arranged in two rings
at adjacent sites are bound in the vestibule of AChBP. We mu-
tated homologous residues in the vestibule of 1 GlyR and ob-
served a reduction in the single channel conductance, suggest-
ing a role of this site in ion permeation. Taken together, our
results demonstrate that targeted modification of a conserved
aromatic residue in loop D is sufficient for a conformational
switch of AChBP and that a defined region in the vestibule of
the extracellular domain contributes to ion conduction in an-
ion-selective Cys-loop receptors.
Cys-loop receptors (CLRs)2 belong to a class of ligand-
gated ion channels that are involved in fast synaptic transmis-
sion in the central nervous system and the neuromuscular
junction. This transmission can either be excitatory or inhibi-
tory depending on the charge of ions that pass through the
ion conduction pathway of the channel. Excitatory transmis-
sion is mediated by nicotinic acetylcholine receptors (nAChR)
and 5-HT3 serotonin receptors, which selectively pass cations.
On the other hand, inhibitory transmission is mediated by
glycine receptors (GlyR) and -aminobutyric acid (GABAA
and GABAC) receptors, which selectively conduct anions. In
both types of receptors, the ion conduction pathway lies along
the central axis formed by five channel subunits, which can
either be identical for homomeric CLRs or non-identical for
heteromeric CLRs. Opening and closing of the ion conduction
pathway is controlled by a gate that is allosterically coupled to
the extracellular ligand-binding domain (for a recent review
see Ref. 1).
Detailed structural data are still lacking for an intact eu-
karyotic CLR, but structural information has been obtained
from 4 Å resolution electron microscopic images of the Tor-
pedo nAChR (2) and higher resolution x-ray crystal structures
of AChBP, a molluscan homolog of the extracellular domain
of nAChRs (3, 4), the monomeric 1 nAChR subunit (5), and
two prokaryotic homologs ELIC (6) and GLIC (7, 8), which
presumably represent the closed and open state of a CLR. De-
spite their different pharmacological properties, these CLRs
share a common architectural arrangement of aromatic resi-
dues in their ligand-binding site. The ligand-binding site for
CLRs is found at the interface between two subunits and li-
gands interact with amino acids from both the principal face
(containing loops A, B, and C) and complementary face (con-
taining loops D, E, and F). We have focused our attention on
an aromatic residue that lies on the complementary face of
the binding pocket and is highly conserved among eukaryotic
and prokaryotic CLRs.
Recently, we found that the tryptophan residue at position
55 of the rat 7 nAChR (Trp-55) was the site where synthetic
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peptides derived from apolipoprotein E non-competitively
inhibited 7 receptors through hydrophobic interactions (9).
In addition, when Trp-55 was mutated to alanine, the 7
W55A nAChR desensitized more slowly and recovered from
desensitization more rapidly than wild-type receptor (10).
Mutating Trp-55 to other aromatic residues (Phe or Tyr) had
no significant effect on the kinetics of desensitization,
whereas mutation to various hydrophobic residues (Ala, Cys,
or Val) significantly decreased the rate of onset and increased
the rate of recovery from desensitization (10). To gain insight
into possible structural rearrangements during desensitiza-
tion, we probed the accessibility of Trp-55 by mutating
Trp-55 to cysteine (7 W55C) and tested the ability of various
sulfhydryl reagents to react with this cysteine (10). Modifica-
tion with several positively charged sulfhydryl reagents, in-
cluding [2-(trimethylammonium)ethyl] methanethiosulfonate
(MTSET), produced 7 W55C nAChRs that became unre-
sponsive to acetylcholine, whereas a neutral sulfhydryl rea-
gent methyl methanethiolsulfonate (MMTS) enhanced acetyl-
choline-activated currents by nearly 60% (10). These data
suggested that Trp-55 plays an important role in both the on-
set and recovery from desensitization in the rat 7 nAChR,
and suggested that Trp-55 may be a potential target for mod-
ulatory agents operating via hydrophobic interactions.
However, these data left unresolved how modification of
loop D with MTSET or MMTS leads to two clearly distinct
functional effects. MTSETmodification renders 7 W55C
receptors unresponsive to acetylcholine, whereas MMTS
modification produces receptors with enhanced responses to
acetylcholine. In this study, we used AChBP to determine x-
ray crystal structures of the homologous Y53C mutant modi-
fied either with MTSET alone or MMTS in the presence of
acetylcholine. We investigated whether structural changes of
methanethiosulfonate (MTS)-modified AChBP correlate with
the opposing functional effects of MTSET and MMTS ob-
served on 7 W55C nAChRs.
MATERIALS ANDMETHODS
AChBP-Y53C Expression, Purification, and MTSET
Modification—The mutant cDNA encoding Y53C AChBP
from Aplysia californica was engineered using a QuikChange
strategy (Stratagene) and verified by sequencing. Baculovirus
was produced using the Bac-to-Bac expression system accord-
ing to the manufacturer’s guidelines (Invitrogen). Untagged
AChBP-Y53C was expressed in Sf9 insect cells and purified as
previously described (11). In brief, medium from Sf9 cells was
harvested 3–4 days after infection with P2 baculovirus and
concentrated on Q Sepharose Fast Flow (GE Healthcare).
Y53C AChBP was further purified by size exclusion chroma-
tography on a Superdex 200 column and ion exchange on a
monoQ column (GE Healthcare). C-terminally His-tagged
Y53C AChBP was purified on a Ni-Sepharose column (GE
Healthcare) and pentameric protein was isolated on a Super-
dex 200 gel filtration column. Protein was concentrated to
5–6 mg/ml on a Centriprep filter (Amicon) with a cut-off of
30 kDa.
[2-(trimethylammonium)ethyl]Methanethiosulfonate bro-
mide (MTSET) and methyl methanethiolsulfonate (MMTS)
were purchased from Toronto Research Chemicals. MTSET
was dissolved in DMSO at a concentration of 1 M, and ali-
quots were stored at20 °C. Dilutions of 100 mM MTSET
were prepared fresh in double-distilled water and stored on
ice immediately before starting covalent protein modification.
Modification of Y53C AChBP with MTSET or MMTS was
carried out on ice at a final concentration of 1 mM MTSET
or MMTS during 1 h. To ensure maximal modification of
AChBP-Y53C a second aliquot of MTS reagent was added
and the reaction was extended for another hour. Covalent
modification of Y53C AChBP with MTSET or MMTS was
analyzed with mass spectrometry. Non-reacted MTS reagents
or hydrolysis products were removed from the protein solu-
tion by dialysis prior to crystallization.
Mass Spectrometry of MTS-modified AChBP-Y53C—The
AChBP protein sample (3 g/l) was mixed with 10 l of dis-
solution buffer (0.5 M TEAB; ABI) and 8 l of trypsin solution
(20 g/ml) (sequencing grade from Promega). After incuba-
tion overnight at room temperature, the sample was loaded
into a C18 Ziptip, and peptides were eluted with 2 l of 80%
acetonitrile/7.0 mM TFA. Of the eluant 0.5 l was spotted on
a MALDI metal plate, mixed with 1 l of matrix (7 mg of
-cyano-4-hydroxycinnamic acid in 1 ml, 50% acetonitrile,
0.1% TFA, 10 mM ammonium phosphate), and analyzed on a
ABI 4800 Proteomics Analyzer (Applied Biosystems). CID
was performed at 2KV, the collision gas was air. MS/MS spec-
tra were collected from 2500 laser shots. MALDI MS and
MALDI/MS/MS analysis of the protein digests was used to
identify and map the sites of modification. This mass spec-
trometry analysis showed that75% of Cys-53 was modified
by MTSET, the remaining fraction is unmodified Cys-53
even in the presence of excess amounts of MTSET. For
MMTS-modified protein the analysis indicated that90% of
Cys-53 is covalently bound to MMTS.
Crystallization and Structure Determination of MTSET-
modified AChBP-Y53C—Initial crystallization screens were
carried out at 20 °C using nanoliter-dispensing robotics (TTP
Labtech). Optimal crystals for AChBP Y53C-MTSET grew
at 4 °C under the following chemical conditions: 150 mM
KSCN, bistrispropane, pH 8.5, and 14% PEG3350. Cryopro-
tection was achieved by adding glycerol to the mother liquor
in 5% increments to a final concentration of 25%. AChBP
Y53C-MMTS was co-crystallized with acetylcholine at a final
protein concentration of 6 mg/ml and 3 mM acetylcholine.
Optimal crystals grew at 4 °C under the following chemical
conditions: 200 mM NH4(H2PO4), 100 mM Tris, pH 8.5, and
50% MPD. Cryoprotection was achieved by a quick crystal
soak in the well solution. Crystals were flash-cooled by im-
mersion in liquid nitrogen.
Diffraction data for Y53C-MTSET were collected to 3.0 Å
at beamline ID14–1 of the European Synchrotron Radiation
Facility (ESRF, Grenoble). The structure was solved by molec-
ular replacement using MOLREP (12) and the unliganded
Aplysia AChBP structure with PDB code 2UZ6. The model
contains two pentamers in the asymmetric unit and was re-
fined using PHENIX (13) with TLS and NCS restraints. Man-
ual building was carried out using COOT (14). The MTSET-
modified side chain at position 53 was built into the simple
Structure of MTS-modified AChBP
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Fo Fc density map after refinement of a model in which the
side chain at position 53 was omitted. Coordinates and topol-
ogy file for MTSET were obtained from the PRODRG server
(15). The occupancy of MTSET at each of the 10 binding
sites was refined with PHENIX to an average value of 87%.
Diffraction data for Y53C-MMTS in complex with acetyl-
choline were collected to 2.7 Å at beamline ID23–2 (ESRF,
Grenoble). The structure was solved by molecular replace-
ment and refined using a strategy similar to the one described
above. The model contains one pentamer in the asymmetric
unit and was refined with BUSTER (16) using TLS and NCS
restraints. Inspection of the simple Fo Fc density map re-
vealed two noticeable blobs in each binding pocket. Acetyl-
choline molecules were manually placed into density with
COOT using coordinates and restraints obtained from the
PRODRG server. The MMTS-modified side chain was built
into Fo Fc density map after refinement of the model in
which the side chain at position 53 was omitted. Diffraction
data were processed with MOSFLM for the Y53C-MTSET
data set and XDS for the Y53C-MMTS data set. Validation of
the final model was carried out with MOLPROBITY (17, 18).
All model figures were prepared with PYMOL (DeLano
Scientific).
Competitive Binding Assays with AChBP-Y53C—Competi-
tion binding assays were performed in buffer (PBS, 20 mM
Tris, 0.05% Tween, pH 7.4) in a final assay volume of 100 l.
[3H]epibatidine (GE Healthcare, specific activity 56 Ci/mmol)
was used as the radioligand at 2.23 nM. Ligand was added to
10–50 ng His-tagged Y53C AChBP, mixed with 200 g PVT
Copper His-Tag SPA beads (GE Healthcare) and incubated
for 1.5 h at room temperature under continuous shaking. The
SPA beads were allowed to settle during 2–4 h and the radio-
activity was measured in a Wallac 1450 MicroBeta liquid scin-
tillation counter. All radioligand binding data were evaluated
by a nonlinear, least-squares curve fitting procedure using
Graphpad Prism (version 5, GraphPad Software, Inc., San Di-
ego, CA). All data are represented as the mean S.E. from at
least three independent experiments.
Single Channel Recordings from 1 GlyRs—Human embry-
onic kidney 293 (HEK) cells were cultured in DMEMmedium
supplemented with 10% FBS, 100 units/ml penicillin and 100
mg/ml streptomycin, in a humidified incubator at 37 °C and
5% CO2. HEK cells were co-transfected with GFP and wild-
type or mutant 1 GlyR cDNA using a calcium phosphate
transfection kit (Invitrogen) according to the manufacturer’s
instructions. Cover slips containing transfected HEK cells
were transferred to a chamber containing (in mM): 140 NaCl,
4 KCl, 2 CaCl2, 2 MgCl2, 10 glucose, and 10 HEPES; pH was
adjusted to 7.4 with NaOH. Cells were visualized using a Ni-
kon Eclipse TE300 microscope equipped for fluorescence de-
tection. Borosilicate patch pipettes (3–6 M) were filled with
extracellular solution containing 100 M glycine. Currents
were recorded in the cell-attached configuration at30,60,
and90 mV. Experiments were performed at room tempera-
ture (22 °C) using an Axopatch-200A amplifier connected to a
Digidata 1322A and pCLAMP software (version 10.1). Cur-
rents were filtered at 1 kHz and digitized at 10 kHz.
RESULTS
X-ray Crystal Structures of MTS-modified Y53C AChBP—
To investigate whether AChBP is a valid tool for structural
studies of MTS-modified cysteine mutants, we investigated
the pharmacological effects of MTSET- and MMTS-modifi-
cation on the homologous Y53C mutant in AChBP from
Aplysia californica, Ac-AChBP (see Table 1). Mutation of
Tyr-53 to cysteine leads to a reduction of [3H]epibatidine
binding, whereas MMTS modification does not significantly
alter binding. Nicotine displacement is significantly lowered
in both Y53C and its MMTS-modified protein. However, ace-
tylcholine binding is selectively affected only in the MMTS-
modified Y53C, suggesting that acetylcholine may address a
different binding configuration. Upon modification with
MTSET, no binding with [3H]epibatidine could be detected.
This parallels the observation that 7 W55C nAChRs become
unresponsive to acetylcholine after modification with
MTSET (10). Combining these data suggest that AChBP
Y53C is sensitive to modification with MTS reagents and pro-
vides a model to understand the effects of MMTS and
MTSETmodification at the structural level.
Next, we determined crystal structures of Ac-AChBP in
which the homologous aromatic residue Tyr-53 was mutated
to cysteine and subsequently modified with either MTSET
or MMTS. The crystal structure of Ac-AChBP Y53C with
MTSET was solved from diffraction data to a resolution of 3
Å (Table 2). The asymmetric unit contains two pentamers,
which are in an upside-down orientation relative to each
other and interact through an interface that involves two
neighboring C-loops (Fig. 1A). As a result of this crystal con-
tact, one of these C-loops is more contracted compared with
the conformation of all other C-loops in this pentamer (see
supplemental Fig. S1). Mass spectrometry of MTSET-modi-
fied Y53C and inspection of difference electron density maps
indicated the attachment of an MTSET side chain to Y53C
(Fig. 1A). Contact analysis of surrounding residues in the li-
gand-binding pocket shows that the MTSET side chain in-
teracts with the side chains of Gln-36 and Ser-165 in loop F
and Tyr-91 in loop A (Fig. 1A). Superposition of each of the 5
monomers shows a variable conformation of the MTSET
side chains (see supplemental Fig. S1). Together with partial
covalent modification, flexibility of the MTSET side chain
might account for the weak electron density observed at some
positions in the crystal structure. High flexibility of the
MTSET side chain and partial density was also observed in
TABLE 1
Binding affinities of epibatidine, nicotine, and acetylcholine for wild
type Ac-AChBP, Y53C AChBP, and the MMTS- andMTSET-modified
Y53C proteins
Student’s t-test was used to determine significance levels.
Kd 3HEB Ki nicotine Ki acetylcholine
nM M M
wt Ac-AChBP 8.47 1.93 0.77 0.06 64.4 8.6
Y53C 26.76 4.02a 2.78 0.47b 60.65 2.53
Y53C-MMTS 19.11 3.77a 3.05 0.28b 98.3 0.8a
Y53C-MTSET NBc NB NB
a Different from wt p 0.05.
b Different from wt p 0.001.
cNB, no binding.
Structure of MTS-modified AChBP
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the crystal structure of MTSET-modified Sortase B from
Staphylococcus aureus (PDB code 1QWZ), despite the higher
resolution (1.7 Å) of the diffraction data (19).
The conformational state of loop C and its relative contrac-
tion was quantified by measuring the distance between the
carbonyl oxygen atom of the conserved Trp-145 and the
-sulfur atom of Cys-188 in each subunit of the pentamer
(Fig. 2). For one of the C-loops involved in the crystal contact
this distance is 7.9 Å, compared with 12.45 1.88 Å in all
other subunits (magenta, Fig. 2). In comparison, this distance
amounts to 7.23 0.10 Å for loop C in a contracted confor-
mation of the published nicotine-bound structure of AChBP
(green, Fig. 2 and Ref. 20) and 14.38 0.13 Å for loop C in an
extended conformation of the -conotoxin-bound structure
(red, Fig. 2 and Ref. 11). The published crystal structure for
apo AChBP revealed a disordered loop C (yellow, Fig. 2 and
Ref. 21), which is most likely due to an intrinsic mobility of
this loop in the unliganded state (22). These data indicate that
MTSET-modification of Cys-53 stabilizes Ac-AChBP in a
conformational state that is similar to the antagonist-bound
complexes with -conotoxins (Fig. 2). This observation paral-
lels the effect of MTSET-modification on 7 W55C
nAChRs, which produces receptors unresponsive to saturat-
ing concentrations of acetylcholine.
To gain more insight into the potentiating effect of MMTS-
modification of 7 W55C nAChRs upon application of acetyl-
choline, we also solved a crystal structure of MMTS-modified
Y53C-AChBP in complex with acetylcholine. Mass spectrom-
etry analysis of MMTS-modified Y53C AChBP indicated that
90% of the protein was covalently modified in the presence
of excess amounts of MMTS. The crystal structure for
MMTS-Y53C in complex with acetylcholine was solved from
diffraction data to a resolution of 2.8 Å (Fig. 1B and Table 2).
Difference electron density maps indicate that the cysteine
side chain at position 53 was modified and that acetylcholine
molecules occupy each of the five binding pockets (ACh1, Fig.
1B) at a position that is almost identical to the published car-
bamylcholine-bound structure of Ls-AChBP (Fig. 1D, CCh
and Ref. 20). The quaternary amine group of ACh1 forms a
cation- interaction with the conserved aromatic residues of
the principal face (shown in yellow in Fig. 1B). Unexpectedly,
electron density near the MMTS-modified side chain indi-
cates the occupancy of a second acetylcholine molecule in the
same binding pocket (ACh2, Fig. 1B). Contact analysis shows
that the MMTS side chain closely interacts with this second
acetylcholine molecule, together with residues of the comple-
mentary face, namely Thr-34, Gln-36, and Ser-165 (Fig. 1B).
The conformation of loop C in this crystal structure was com-
pared with the MTSET-modified Y53C structure by mea-
suring the distance between carbonyl oxygen atom of Trp-145
and the -sulfur atom of Cys-188, which amounts to 7.18
0.02 Å (blue, Fig. 2). Together, these data show that the con-
formational state of MMTS-Y53C in complex with acetylcho-
line is distinct fromMTSET-Y53C and offer a possible ex-
planation for the potentiating effect of MMTS on
acetylcholine-evoked currents in 7 W55C nAChRs.
Phosphates Ions Are Bound in the Vestibule of AChBP—Sur-
prisingly, we also found peaks in the difference map that are
TABLE 2
Crystallographic andmodel refinement statistics
Ac-AChBP Y53CMTSET Ac-AChBP Y53CMMTSacetylcholine
Data statistics
Wavelength (Å) 0.9334 0.8726
Spacegroup P41 21 2 C2221
Unit cell parameters (Å) a	 b	 144.8, c	 274.6 a	 82.1, b	 119.4, c	 267.7
Resolution limits (Å) 100-3.15 (3.32-3.15) 47.6-2.80 (2.87-2.80)
Rsyma (%) 18.2 (41.3) 13.3 (59.4)
Rmeasb (%) 20.1 (45.8) 16.7 (71.7)
Rpimc (%) 8.5 (19.4) 7.1 (44.6)
I/(I) 4.1 (1.9) 11.8 (1.9)
Multiplicity 5.3 (5.4) 5.9 (3.3)
Data completeness (%) 98.3 (98.9) 92.2 (77.5)
Number unique reflections 50724 (7358) 31966 (2244)
Wilson B factor 31.6 50.5
Refinement and model statistics
R-factord (%) 18.6 17.3
Rfreee (%) 23.6 21.9
RMSD bond distance (Å) 0.008 0.010
RMSD bond angle (°) 1.07 1.09
Average B-factors 63.0 (protein) 47.1 (protein)
90.1 (MTSET side chain) 59.7 (MMTS side chain)
52.5 (ACh1)
105.9 (ACh2)
106.7 (PO43)
38.1 (H2O)
Ramachandran analysisf
Number of residues in favorable regions 1595 (86.7%) 834 (89.7%)
Number of residues in additional allowed regions 244 (13.25%) 96 (10.3%)
Number of residues in disallowed regions 1 (0.05%) 0 (0.0%)
Total number of residues 2060 1040
a
hkl
iIi(hkl) I(hkl) /
hkl
iIi(hkl), where 
hkl denotes the sum over all reflections, and 
i is the sum over all equivalent and symmetry-related reflections.
bRmeas	 
hkl(N/(N 1)) 
iIi(hkl) I(hkl) /

hkl
iIi(hkl).
c Rpim	 
hkl(1/(N 1)) 
iIi(hkl) I(hkl) /
hkl
iIi(hkl).
dR-factor	 
 Fobs Fcalc /
Fobs.
e Rfree	 R-factor for 5% of the data were not included during crystallographic refinement.
f Ramachandran analysis was carried out with PROCHECK in the CCP4 suite.
Structure of MTS-modified AChBP
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localized in the vestibule of AChBP (Fig. 3, A and B). These
peaks were interpreted as phosphate ions, which were present
in the crystallization solution at a concentration of 200 mM. In
total, there are ten phosphate ions bound in the vestibule,
which are arranged in two pentagonal layers. The upper layer
contains five phosphate ions at a distance of 9 Å apart (Fig.
3D, ring 1) that occupy the same positions as sulfate ions ob-
served in a previous study (23). These sulfates are stabilized
through interaction with Arg-95, which is in an equivalent
position to a conserved positively charged residue in anion-
selective Cys-loop receptors and a conserved negatively
charged residue in cation selective receptors (for example,
Asp-97 in the muscle 1 nAChR subunit). This residue, which
lies near the transmembrane interface, was therefore sug-
gested to stabilize cations before entry into the channel pore
(23). However, in the MMTS-Y53C crystal structure, we find
a second layer of phosphate ions in a pentagonal arrangement
at a closer distance of 7 Å apart (Fig. 3D, ring 2). Phosphates
in this lower ring interact directly with Lys-40 or through wa-
ter molecules involved in hydrogen bonds with Glu-47 and
FIGURE 1. A, left, crystal structure of Aplysia Y53C AChBP modified with MTSET. The asymmetric unit contains two pentamers, which are in an upside-down
orientation relative to each other and interact through two neighboring C-loops (indicated with arrow). The MTSET-modified side chain is shown as
spheres. Right, detailed stereoview of the ligand-binding pocket at the interface of two subunits. The principal face () is shown in yellow, complementary
face () in blue. Conserved aromatic amino acids of the principal face as well as residues involved in interactions with the MTSET-modified side chain (Gln-
36, Tyr-91, and Ser-165) are shown in stick representation. 2Fo Fc electron density around the Cys-55 side chain is shown as blue meshwith a contour level
of 1.0 sigma. B, left, co-crystal structure of Y53C AChBP modified with MMTS and acetylcholine. The asymmetric unit contains 1 pentamer, shown along the
5-fold symmetry axis. The MMTS side chain and acetylcholine molecules are shown in sphere representation. Right, detailed stereoview of the ligand-binding
pocket formed by a principal (yellow) and complementary (blue) subunit. Residues involved in ligand-receptor interactions are shown in stick representation.
2Fo Fc density around the acetylcholine molecules and MMTS-modified side chain is shown as a blue mesh at a contour level of 1.0 sigma. C, sequence
alignment showing the conservation of an aromatic amino acid (shown in “black”) in loop D of different Cys-loop receptors. D, stereoview of ligand contacts
in the published crystal structure of Lymnaea AChBP in complex with a single carbamylcholine molecule (PDB code 1UV6 and Ref. 20).
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Asp-49 in AChBP. A detailed interaction of residues and sur-
rounding water molecules involved in hydrogen bonding of
phosphate ions is shown in Fig. 3C.
The observation that sulfates as well as phosphates bind in
a defined location of the vestibule of AChBP suggests that this
region functions as a general anion-binding site. Therefore,
we questioned whether chloride anions may interact in a sim-
ilar manner in the vestibule of anion-selective Cys-loop recep-
tors, such as GABAA-R and GlyR. Sequence alignment with
other Cys-loop receptors indicates that a residue of ring 1
(Arg-95 in Ac-AChBP) matches a conserved negatively
charged residue, for example Asp-97 in 1 nAChR (Fig. 4A).
In contrast, anion-selective Cys-loop receptors contain 1 or 2
adjacent positively charged residues at this position, for exam-
ple Lys-105/Lys-106 in the 1 GABAA-R and Lys-104/Gly-
105 in the 1 GlyR. Additionally, alignment of residues
Glu-47 and Asp-49 in ring 2 of AChBP indicates the conser-
vation of a negative charge in anion-selective Cys-loop re-
ceptors, for example Glu-59 in the 1 GABAA-R and
Asp-57 in the 1 GlyR (Fig. 4A).
We investigated whether residues of ring 1 and ring 2 have
a conserved role as anion-binding sites in the anion-selective
1 GlyR. Therefore, we mutated positions K104A and G105D
(ring 1) and D57I and R59T (ring 2) to the corresponding resi-
dues in the 1 nAChR. Expression into Xenopus oocytes
showed that these mutants were functional and had a reversal
potential that was identical to wild-type 1 GlyR (data not
shown), indicating that ion selectivity is not affected. Next, we
investigated whether charge alterations affect the conduct-
ance of Cl ions and recorded single channel activity evoked
by 100 M glycine in the cell-attached configuration on
HEK293 cells expressing 1 GlyR mutants (Fig. 4, B–E). Com-
pared with wild-type GlyR, the mutants show a decreased
current amplitude at all potentials tested (Fig. 4, B–E). A cur-
rent amplitude versus potential plot is linear (data not shown),
allowing us to calculate the unitary conductance (slope of the
line). The single channel conductance was decreased by 40%
for mutant ring 1, by 60% for mutant ring 2, and by 70% for
the quadruple mutant ring 1 2 (Fig. 4F). The effects of these
mutations in ring 1 and ring 2 on single channel conductance
were not additive since the quadruple mutation shows con-
ductance levels similar to mutant ring 2. Furthermore, the
ring 2 mutations result in the loss of activity at30 mV sug-
gesting that these residues are not only critical for channel
conductance, but may also be involved in gating. These results
demonstrate that conserved charges at two adjacent sites in
the extracellular domain of the 1 GlyR contribute to ion se-
lection and permeation. Coordinates and structure factors for
Y53C-MTSET and Y53C-MMTS with acetylcholine have
been deposited in the Protein Data Bank with accession codes
2XZ6 and 2XZ5, respectively.
FIGURE 2. Comparison of C-loop conformation for Y53C-MTSET (ma-
genta), Y53C-MMTS in complex with acetylcholine (blue), nicotine-
bound state (green, PDB code 2BR7, Ref. 20), -conotoxin ImI-bound
state (red, PDB code 2C9T, Ref. 11), and apo state (yellow, PDB code
2W8E, Ref. 21). The dashed lines indicate the distances between the car-
bonyl oxygen of the conserved Tyr-145 residue in Aplysia AChBP and the S
atom of the vicinal disulfide bond.
FIGURE 3. A, MMTS-Y53C crystal structure of AChBP shows localized phosphate ions in the vestibule. The pentamer is shown along the 5-fold axis of sym-
metry with the N terminus pointing away from the viewer. B, detailed view of the anion-binding site in AChBP as seen along the 5-fold symmetry axis from
the intracellular side. Ten phosphate ions (yellow) are bound and interact with Lys-40 and Arg-95 (green), Glu-47 and Asp-49 (orange). Phosphate ions and
interacting residues are shown in stick representation. The blue mesh around phosphate ions is electron density from a 2Fo Fc map contoured at a level of
1.0 sigma. Dashed lines indicate distances between two neighboring phosphate ions, 9.3 Å for the upper layer (ring 1), and 7.1 Å for the lower layer (ring 2).
C, detailed interaction of residues from a single subunit with phosphate ions in the vestibule. Water molecules are represented as red spheres. Dashed lines
indicate hydrogen bonds. D, stereoview from the side of the anion-binding site shows two layers of phosphate ions in a pentagonal arrangement. For clar-
ity, phosphate ions are shown as yellow sphereswith a radius of 1 Å. The upper layer (ring 1) matches the position of bound sulfate ions in a previously pub-
lished study (23).
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DISCUSSION
Substituted cysteine accessibility scanning (SCAM) is a
widely used method to study the relationship between struc-
ture and function of ion channels (24). With the availability of
an increasing number of x-ray crystal structures for ion chan-
nels, SCAM is now frequently employed to test the validity of
three-dimensional models in the context of channel dynamics
and their lipid membrane environment (25–27). SCAM has
powerful advantages in that the method allows real-time
monitoring of the reaction speed between the MTS reagent
and the targeted cysteine residue for the closed, open, or de-
sensitized state of the channel. However, this reaction is typi-
cally followed indirectly by measuring changes in the func-
tional properties of ion channels such as ion conduction,
voltage dependence of activation or ligand activation. Because
of the indirect nature of this method, it is not always possible
to establish a clear relationship between the observed func-
tional effects of MTS modification and the underlying confor-
mational changes of the channel.
In this study, we report the first x-ray crystal structures of
an MTS-modified cysteine mutant of the nAChR homolog
AChBP. We used the homologous mutant of 7 W55C
nAChRs, which is oppositely regulated by two different MTS
reagents, namely MTSET and MMTS (10), to investigate the
correlation between structure and function. We previously
demonstrated that modification of 7 W55C nAChRs with
MTSET produces receptors that become unresponsive to
saturating concentrations of acetylcholine (10). The crystal
structure of MTSET-modified Y53C AChBP shows that
loop C is stabilized in a conformational state that resembles
the antagonist-bound state. This result suggests that the unre-
sponsive behavior of MTSET-modified 7 W55C nAChRs
may arise from a similar stabilization of the receptor in an
antagonist-bound state. This also suggests that the conforma-
tion of loop C is correlated with the activational state of the
receptor. In contrast to MTSET-modified 7 W55C
nAChRs, we previously showed that modification of 7
W55C nAChRs with MMTS enhances acetylcholine-evoked
FIGURE 4. A, side view of the GLIC pore (8) illustrates the relative position of the homologous ring sites and the selectivity filter at the bottom of transmem-
brane segments M1 and M2. The sequence alignment shows the conservation of charged residues in ring 1 (Arg-95 in AChBP) and ring 2 (Glu-47 and
Asp-49 in AChBP) among different members of the Cys-loop receptor family. B, single channel responses were obtained from wild-type and mutant 1 GlyR
using 100 M glycine in the cell-attached configuration at30,60, and90 mV. Mutant ring 1 contains K104A and G105D, mutant ring 2 contains D57I
and R59T, mutant ring 1 2 is the quadruple mutant. B, wild-type 1 GlyR; C, mutant ring 1; D, mutant ring 2; E, mutant ring 1 2. Mutant ring 2 was only
active at60 and90 mV. All-point histograms of current amplitude (bin width of 0.1 pA) were fitted by the sum of two Gaussian functions (right side; B, C,
D, E). F, single channel conductances were derived from the slope of the current-voltage relationship; (72 pS) wild type, (46 pS) mutant ring 1, (27 pS) mu-
tant ring 2, and (23 pS) mutant ring 1 2.
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currents by nearly 60% (10). The crystal structure of MMTS-
modified Y53C AChBP shows that loop C is strongly con-
tracted, similar to other agonist-bound structures. We also
observed that two acetylcholine molecules occupy the binding
pocket, which possibly explains the potentiating effect of ace-
tylcholine on MMTS-modified 7 W55C nAChRs. One of
these acetylcholine molecules faces the principal binding site
and occupies a position that overlaps with the binding mode
observed in the related carbamylcholine-bound structure of
AChBP. The second acetylcholine molecule interacts with
residues of the complementary face, including the MMTS-
modified side chain of Cys-53. Therefore, we propose that the
potentiating effect of MMTS on 7 W55C nAChRs arises
from a favorable interaction with the MMTS-modified side
chain that stabilizes two acetylcholine molecules in the li-
gand-binding site. Together, both AChBP crystal structures
parallel our observations from functional studies on 7 W55C
nAChRs, and offer possible explanations for the opposing
effects of MTSET and MMTS. Our results suggest that tar-
geted modification of a single residue in loop D is sufficient to
trigger conformational changes of AChBP.
The functional importance of residues in loop D has been
demonstrated by mutagenesis studies in different CLRs. Mu-
tation of the homologous W55 residue in the GABAA-R 2-
subunit, F77C, abolished binding by [3H]Ro15–1788 and the
benzodiazepine [3H]flunitrazepam. Mutation of neighboring
residues in loop D, A79C and T81C, caused a 10-fold reduc-
tion in the affinity of the tranquilizers eszopiclone and zolpi-
dem (28). In the GABAA-R 1-subunit, it was shown that for
the homologous Trp-55 subtle changes were caused by unnat-
ural amino acid mutations (29). In the muscle nAChR it was
shown that mutation W57F in the -subunit and W55F in the
-subunit have only minor effects on acetylcholine-sensitivity
but mainly affect channel gating by reducing the channel
opening rate (30). In insect nAChRs, it was shown that the
basic Arg and Lys residues at positions2 and4 of the ho-
mologous W55 residue are responsible for the high affinity of
the insecticide imidacloprid and related neonicotinoids (31).
Mutation of loop D residues N55S and V56I in the human
nAChR 4-subunit, which are at positions2 and1 of the
homologous Trp-55 residue, abolishes sensitivity to TMAQ, a
novel agonist for 4-containing nAChRs (32). In a related
study it was shown that mutations N55S, V56I, T59K, and
E63T in the human nAChR 2-subunit reduce the affinity of
acetylcholine and nicotine, while having little to no effect on
the affinity of epibatidine and dimethylphenylpiperazinium
(DMPP) (33).
In addition to loop D, accumulating evidence implicates
loop C as a structural component that is key to both ligand
binding and subsequent conformational changes underlying
CLR activation, inhibition, and desensitization (34). The im-
portant role of loop C derives from a large body of work using
x-ray crystallography (11, 35–37), molecular dynamics simu-
lation (38–40), site-directed mutagenesis (41–44), and elec-
trophysiology (45, 46). The data from these studies demon-
strates that loop C is flexible in the non-liganded form (22, 37)
and adopts distinct conformations upon agonist or antagonist
binding. Loop C assumes a contracted configuration with
agonists bound (corresponding to either the open or desensi-
tized state of the receptor) and takes on an extended configu-
ration with antagonists bound (corresponding to the closed
state of the channel (11, 35, 36). More recent work suggests
that the degree of loop C movement may correspond to ago-
nist efficacy (37). Movement in the ligand binding domain is
thought to propagate from the extracellular domain to the
pore region to allow activation or inhibition of ion flux. This
transduction of signal can be understood both as a sequence
of chemical events (47) or as coordinated movements or rota-
tions of the whole extracellular domain (40, 48, 49).
Unexpectedly, we observed electron density that could be
interpreted as phosphate ions in the vestibule of AChBP at a
location that is very near to the interface with the transmem-
brane domain in integral Cys-loop receptors. The contribu-
tion of rings of charged amino acids to channel conductance
has previously been demonstrated in the Torpedo nAChR
(50), but detailed insight into the mechanism of ion conduc-
tion was lacking. Structural insight into selection of ions in
the extracellular domain of Cys-loop receptors was obtained
from a crystal structure containing 5 sulfate ions near residue
Arg-95 in the vestibule of AChBP (23). Hansen et al. demon-
strated that this residue, which corresponds to a highly con-
served Asp in cation-selective Cys-loop receptors, affects sin-
gle channel conductance upon charge reversal mutations in
the muscle nAChR. In our structure, we observe 10 phosphate
ions bound to a cluster of charged residues that involve Lys-
40, Glu-47, Asp-49, and Arg-95. The phosphate ions are ar-
ranged in two pentagonal layers separated by a distance of less
than 4 Å. The 5 phosphate ions in the upper layer (ring 1)
occupy the same positions as the sulfate ions in the study
from Hansen et al. and are arranged at a distance of 9 Å apart.
Phosphate ions in the lower layer (ring 2) are spaced at a dis-
tance 7 Å apart and interact with Lys-40, Glu-47, and Asp-49.
The observation that sulfates as well phosphates bind in a
defined location of the vestibule of AChBP suggests that this
region functions as a general anion-binding site. One of the
binding site residues, Glu-47, is strictly conserved as a nega-
tively charged amino acid (Asp or Glu) in anion-selective Cys-
loop receptors, and hydrophobic (M, I, or V) in cation-selec-
tive Cys-loop receptors. Therefore, we hypothesized that
chloride anions may interact in a similar manner with con-
served negatively charged residues in anion-selective Cys-loop
receptors, such as GABAA-R and GlyR. We demonstrated
that mutation of homologous residues in ring 1 and ring 2 of
the 1 GlyR causes a pronounced reduction in the single
channel conductance. This result suggests a functional role of
the extracellular domain of 1 GlyR in selection and perme-
ation of anions. Our observation fits with molecular dynamics
simulations of the nAChR (51) and the bacterial homolog
GLIC (52), which demonstrated the existence of one or more
cation reservoirs in the extracellular domain of these cation-
selective Cys-loop receptors.
In conclusion, our study shows a good correlation between
structure and function, and offers possible explanations for
the opposite effects of MTSET and MMTS on 7 W55C
nAChRs. We show that targeted modification of loop D plays
a key role in defining the conformational state of AChBP.
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This hints at a contribution of a conserved aromatic residue
in loop D that goes beyond its established role of shaping the
ligand-binding site. This residue may contribute to a struc-
tural switch that discriminates between the activated and
non-activated state of Cys-loop receptors. In addition, the
unexpected observation of phosphate anions bound in the
vestibule of AChBP parallels the functional role of two rings
of charged residues in the extracellular domain of the 1 GlyR
that contribute to ion selection and permeation.
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